Loxivil-P Tablet is a combination analgesic and anti-inflammatory medication containing Lornoxicam 8 mg and Paracetamol 325 mg. Lornoxicam, a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class, provides potent analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis involved in pain and inflammation. Paracetamol, an analgesic and antipyretic agent, acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. The synergistic combination in Loxivil-P offers effective relief from mild to moderate pain associated with musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, postoperative pain, dental pain, and other inflammatory conditions. This formulation is particularly beneficial for patients requiring rapid and sustained pain control with reduced gastrointestinal side effects compared to higher doses of NSAIDs alone. Loxivil-P should be administered as directed by a healthcare professional, considering contraindications such as hypersensitivity to NSAIDs or paracetamol, active peptic ulcer, severe hepatic or renal impairment, and bleeding disorders. Caution is advised in patients with cardiovascular risk factors. Regular monitoring is recommended during prolonged therapy. This medication is intended for short-term use to manage acute pain and inflammation effectively.